Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G ↑	Ingredients	Dosage	Form	Price
D06AX01	FUCIDIN CREAM	B	Fusidic acid - 2%	2%	Cream	491,846 L.L
D06AX01	FUCIDIN CREAM	B	Fusidic acid - 2%	2%	Cream	345,368 L.L
M02AA10	FASTUM	B	Ketoprofen - 2.5g/100g	2.5%	Gel	177,387 L.L
M02AA10	FASTUM	B	Ketoprofen - 2.5g/100g	2.5%	Gel	337,304 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	L.L
D06AX01	FUCIDIN	B	Fusidic acid (sodium salt) - 20mg/g	2%	Ointment	259,362 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	491,846 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	345,368 L.L
S01AA13	FUCITHALMIC VISCOUS	B	Fusidic acid - 10mg/g	1%	Drops	443,468 L.L
M02AA15	FLECTOR E.P TISSUGEL	B	Diclofenac (epolamine) - 1%	1%	Patch	1,204,083 L.L
A06AD15	FORLAX POUDRE POUR SOLUTION BUVABLE	B	Macrogol 4000 - 10g	10g	Powder for solution	450,187 L.L
A06AD65	FORTRANS POUDRE POUR SOLUTION BUVABLE	B	Potassium chloride - 0.750g, Sodium chloride - 1460g, Sodium bicarbonate - 1680g, Sodium sulfate anhydrous - 5700g, Macrogol 4000 - 64.000g		Powder for solution	1,136,891 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 250mcg/actutaion	250mcg/actutaion	Inhalation suspension	1,484,946 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 125mcg/actuation	125mcg/actuation	Inhalation suspension	802,274 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Inhalation suspension	671,921 L.L
S01CA01	FRAKIDEX	B	Dexamethasone disodium phosphate - 0.1g/100g, Framycetin sulfate - 0.5g/100g		Ointment	141,103 L.L
G04B	FONCITRIL 4000	B	Citric acid - 1.189g, Potassium Citrate - 1.73g, Sodium citrate - 1.845g		Granules	1,613,955 L.L
A10BK01	FORXIGA	B	Dapagliflozin - 10mg	10mg	Tablet, film coated	2,927,964 L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	L.L
C03BA11	FLUDEX	B	Indapamide - 1.5mg	1.5mg	Tablet, sustained release	517,379 L.L
D07CC01	FUCICORT	B	Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g		Cream	376,276 L.L
D07CC01	FUCICORT	B	Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g		Cream	501,253 L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	214,213,273 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	46,628,557 L.L
M05BB03	FOSAVANCE	B	Alendronic acid (sodium alendronate) - 70mg, Colecalciferol - 5600IU		Tablet	1,988,887 L.L
B03AB02	FERRICURE	B	Iron (polysaccharide complex) - 150mg	150mg	Capsule	1,001,163 L.L
B03AB09	FERPLEX	B	Iron trivalent (ferric proteinsuccinylate) - 800mg	800mg	Solution	1,202,739 L.L
R05CB01	FLUIMUCIL	B	N-acetylcysteine - 600mg	600mg	Tablet, effervescent	567,102 L.L
R05CB01	FLUIMUCIL MUCOLYTIC	B	N-acetylcysteine - 2%	2%	Syrup	595,322 L.L
B03AC	FERINJECT	B	Iron trivalent (ferric carboxymaltose) - 500mg/10ml	500mg/10ml	Injectable solution	10,212,033 L.L